LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) (the “Company” or “Inotek”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that David P. Southwell, President and Chief Executive Officer of Inotek, will present at the 2015 Ophthalmology Innovation Summit at the American Academy of Ophthalmology (OIS@AAO) annual meeting on Thursday, November 12, 2015, at 11:09 a.m. Pacific Time at the Planet Hollywood Las Vegas Resort & Casino.
Help employers find you! Check out all the jobs and post your resume.
